If such a hypothesis turns out to be true, then despite the increase in HDAC6 expression level, HDAC6 deacetylase activity is reduced in AD pathology, possibly leading to dysfunctional HDAC6-regulated cellular processes. This evidence concerns the gene HDAC6 and Alzheimer disease.